rs8729

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_018847.4(KLHL9):​c.*1886G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.262 in 152,352 control chromosomes in the GnomAD database, including 5,608 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.26 ( 5601 hom., cov: 32)
Exomes 𝑓: 0.18 ( 7 hom. )

Consequence

KLHL9
NM_018847.4 3_prime_UTR

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.365

Publications

17 publications found
Variant links:
Genes affected
KLHL9 (HGNC:18732): (kelch like family member 9) This gene encodes a protein that belongs to the kelch repeat-containing family, and contains an N-terminal BTB/POZ domain, a BACK domain and six C-terminal kelch repeats. The encoded protein is a component of a complex with cullin 3-based E3 ligase, which plays a role in mitosis. This protein complex is a cell cycle regulator, and functions in the organization and integrity of the spindle midzone in anaphase and the completion of cytokinesis. The complex is required for the removal of the chromosomal passenger protein aurora B from mitotic chromosomes. [provided by RefSeq, Jul 2016]
KLHL9 Gene-Disease associations (from GenCC):
  • Tourette syndrome
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_018847.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.399 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_018847.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KLHL9
NM_018847.4
MANE Select
c.*1886G>A
3_prime_UTR
Exon 1 of 1NP_061335.1Q9P2J3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KLHL9
ENST00000359039.5
TSL:6 MANE Select
c.*1886G>A
3_prime_UTR
Exon 1 of 1ENSP00000351933.4Q9P2J3
KLHL9
ENST00000718394.1
n.*101-1701G>A
intron
N/AENSP00000520799.1Q9P2J3
KLHL9
ENST00000718395.1
n.*100+1786G>A
intron
N/AENSP00000520800.1Q9P2J3

Frequencies

GnomAD3 genomes
AF:
0.262
AC:
39844
AN:
151804
Hom.:
5592
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.337
Gnomad AMI
AF:
0.168
Gnomad AMR
AF:
0.310
Gnomad ASJ
AF:
0.239
Gnomad EAS
AF:
0.414
Gnomad SAS
AF:
0.161
Gnomad FIN
AF:
0.209
Gnomad MID
AF:
0.250
Gnomad NFE
AF:
0.213
Gnomad OTH
AF:
0.257
GnomAD4 exome
AF:
0.179
AC:
77
AN:
430
Hom.:
7
Cov.:
0
AF XY:
0.171
AC XY:
44
AN XY:
258
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.182
AC:
77
AN:
422
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
2
Other (OTH)
AF:
0.00
AC:
0
AN:
4
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.263
AC:
39894
AN:
151922
Hom.:
5601
Cov.:
32
AF XY:
0.262
AC XY:
19438
AN XY:
74258
show subpopulations
African (AFR)
AF:
0.337
AC:
13947
AN:
41404
American (AMR)
AF:
0.310
AC:
4731
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.239
AC:
827
AN:
3466
East Asian (EAS)
AF:
0.413
AC:
2139
AN:
5176
South Asian (SAS)
AF:
0.163
AC:
784
AN:
4822
European-Finnish (FIN)
AF:
0.209
AC:
2207
AN:
10536
Middle Eastern (MID)
AF:
0.241
AC:
71
AN:
294
European-Non Finnish (NFE)
AF:
0.213
AC:
14494
AN:
67942
Other (OTH)
AF:
0.256
AC:
541
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1457
2914
4371
5828
7285
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
390
780
1170
1560
1950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.254
Hom.:
2096
Bravo
AF:
0.278
Asia WGS
AF:
0.299
AC:
1036
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.78
DANN
Benign
0.70
PhyloP100
-0.36
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs8729;
hg19: chr9-21331119;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.